Search - tctmd.com

Displaying 681 - 700 of 702

Sort: Relevancy | Date

News Conference News

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Jason Kahn

April 03, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Industry News

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

March 28, 2011

News Industry News

Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich’s Genous™ Stent in Diabetic Patients

March 23, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

‘Mother-Child’ Technique Improves Success for PCI in Challenging Lesions

Caitlin E. Cox

March 03, 2011

News Daily News

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

L.A. McKeown

February 28, 2011

News Daily News

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Jason Kahn

February 23, 2011

News Daily News

Paclitaxel-Eluting Balloon Effective for DES Restenosis

February 22, 2011

News Daily News

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

February 13, 2011

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

News Daily News

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

January 18, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Daily News

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

Jason Kahn

January 12, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

News Daily News

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

January 04, 2011

Advertisement

For Bifurcations, 1 Stent Just as Good as 2 Out to 5 Years

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeich’s Genous™ Stent in Diabetic Patients

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

‘Mother-Child’ Technique Improves Success for PCI in Challenging Lesions

Many Cardiovascular Devices Approved by FDA Without Sex-Specific Data

New Dual-Drug DES Adds Cilostazol to Boost Effectiveness of Paclitaxel

Paclitaxel-Eluting Balloon Effective for DES Restenosis

For Bifurcations, 2 Stents Better Than 1 at Reducing Revascularizations

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

DES Linked with More Stent Thrombosis Than BMS 1 Year After Primary PCI

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

PES Show Delayed Healing in STEMI Patients, Clinical Significance Downplayed

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Benefit of Sirolimus Stents Sharply Attenuated in Dialysis Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content